Molecular modification of T4 bacteriophage proteins and its potential application

Folia Microbiologica

Volumn 54, Issue 1, 2009, Pages 5-15

  Kurzepa A ^a   Dabrowska K ^a   Switala Jelen K ^a   Gorski A ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; MAMMALIA; MIRIDAE;

EID: 63749122530     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-009-0002-0     Document Type: Review

References (55)

1. H.W. Ackermann H. Krisch 1997 A catalogue of T4-type bacteriophages Arch.Virol. 142 2329 2345
2. A. Bateman S.R. Eddy V.V. Mesyanzhinov 1997 A member of the immunoglobulin superfamily in bacteriophage T4 Virus Genes 14 163 165
3. I. Benhar 2001 Biotechnological applications of phage and cell display Biotechnol.Adv. 19 1 33
4. H. Bernstein C. Bernstein 1989 Bacteriophage T4 genetic homologies with bacteria and eucaryotes J.Bacteriol. 171 2265 2270
5. Birge E.A: T4 bacteriophage as a model genetic system, pp. 89-123 in Bacterial and Bacteriophage Genetics. Springer-Verlag, New York 2006.
6. J. Borysowski A. Gorski 2004 Phage-display method in experimental therapy of cancer Postepy Hig.Med.Dośw 58 100 107
7. J. Cao Y. Sun T. Berglindh B. Mellgard Z. Li B. Mardh S. Mardh 2000 Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth Biochim.Biophys.Acta 1474 107 113
8. M.P. Conley W.B. Wood 1975 Bacteriophage T4 whiskers: a rudimentary environment-sensing device Proc.Nat.Acad.Sci.USA 72 3701 3705
9. K. Dabrowska A. Opolski J. Wietrzyk K. Switała-Jeleń J. Boratynski A. Nasulewicz L. Lipinska A. Chybicka M. Kujawa M. Zabel B. Dolinska-Krajewska E. Piasecki B. Weber-Dabrowska J. Rybka J. Salwa E. Wojdat M. Nowaczyk A. Gorski 2004 Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of β3 integrin signaling pathway Ada Virol. 48 241 248
10. K. Dabrowska A. Opolski J. Wietrzyk K. Switała-Jeleń J. Godlewska J. Boratynski A. Nasulewicz L. Lipinska 2004 Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumor models Anticancer Res. 24 3991 3995
11. K. Dabrowska K. Switała-Jelen B. Weber-Dabrowska A. Gorski 2005 Bacteriophage penetration in vertebrates JAppl.Microbiol. 98 7 13
12. K. Dabrowska M. Zembala J. Boratynski M. Kujawa K. Switała- Jeleń J. Wietrzyk A. Opolski K. Szczaurska J. Godlewska A. Gorski 2007 Hoc protein regulates the biological effects of T4 phage in mammals Arch.Microbiol. 187 489 498
13. M. Di Giovine B. Salone Y. Martina V. Amati G. Zambruno E. Cundari C.M. Failla I. Saggio 2001 Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage Virology 282 102 112
14. V.P. Efimov I.V. Nepluev V.V. Mesyanzhinov 1995 Bacteriophage T4 as a surface display vector Virus Genes 10 173 177
15. A. Fernandez-Gacio M. Uguen J. Fastrez 2003 Phage display as a tool for the directed evolution of enzymes Trends Biotechnol. 21 408 414
16. A. Fokine P.R. Chipman P.G. Leiman V.V. Mesyanzhinow V.B. Rao 2004 Molecular architecture of the prolate head of bacteriophage T4 Proc.Nat.Acad.Sci.USA 101 6003 6008
17. Gorski A., Borysowski J., Miedzybrodzki R., Weber-Dabrowska B.: Bacteriophages in medicine, pp. 125-157 in S. McGrath, D. van Sinderen (Eds): Bacteriophage Genetics and Molecular Biology. Horizon Scientific Press, Norfolk (UK) 2007.
18. S. Hashemolhosseini D. Montag L. Kramer U. Henning 1994 Determinants of receptor specificity of coliphages of the T4 family. A chaperone alters the host range J.Mol.Biol. 241 524 533
19. T. Häusler 2006 Bug killers Nature Med. 12 600 601
20. J. Jijang L. Abu-Shilbayeh V.B. Rao 1997 Display of PorA peptide from Neisseria meningitidis on the bacteriophage T4 capsid surface Infect.Immun. 65 4770 4777
21. J.D. Karam W.H. Konigsberg 2000 DNA polymerase of the T4-related bacteriophages Progr.Nucl.Acid Res.Mol.Biol. 64 65 96
22. Kniotek M., Ahmed A.M.A., Dabrowska K., Switała-Jelen K., Opolski A., Gorski A.: Bacteriophage interactions with T cells and platelets, pp. 189-192 in Cytokine Network, Regulatory Cells, Signalling, and Apoptosis (Immunology). Monduzzi Editors, Bologna (Italy) 2004.
23. Z. Konthur G. Walter 2002 Automation of phage display for high-throughput antibody development Targets 1 30 36
24. M.C. Kricker J.W. Drake 1990 Heat mutagenesis in bacteriophage T4: another walk down the transversion pathway J.Bacteriol. 172 3037 3039
25. A. Kuhn B. Keller M. Meader F. Traub 1986 Prohead core of bacteriophage T4 can act as an intermediate in the head assembly pathway J.Virol. 61 113 118
26. T.A. Kunkel L.A. Loeb M.F. Goodman 1984 On the fidelity of DNA replication. The accuracy of T4 DNA polymerases in copying φX174 DNA in vitro J.Biol.Chem. 259 1539 1545
27. Kutter E.: Phage Therapy: Bacteriophages as Antibiotics. Evergreen State College. Olympia (WA, USA) 1997.
28. P.G. Leiman S. Kanamaru V.V. Mesyanzhinov F. Arisaka M.G. Rossmann 2003 Structure and morphogenesis of bacteriophage T4 Cel.Mol.Life Sci. 60 2356 2370
29. A. Lorch 1999 Bacteriophages: an alternative to antibiotics? Biotechnol.Develop.Monitor 39 14 17
30. C.R. Merril B. Biswas R. Carlton N.C. Jensen G.J. Creed S. Zullo S. Adhya 1995 Long-circulating bacteriophage as antibacterial agents Proc.Nat.Acad.Sci.USA 93 3188 3192
31. C.R. Merril D. Scholl S.L. Adhya 2003 The prospect for bacteriophage therapy in western medicine Nature Rev.Drug Disc. 2 489 497
32. V.V. Mesyanzhinov P.G. Leiman V.A. Kostyuchenko L.P. Kurochkina K.A. Miroshnikov N.N. Sykilinda M.M. Shneider 2004 Molecular architecture of bacteriophage T4 Biochemistry 69 1190 1202
33. L.M. Mullen S.P. Nair J.M. Ward A.N. Rycroft B. Henderson 2006 Phage display in the study of infectious diseases Trends Microbiol. 14 141 147
34. F. Nilsson L. Tarli F. Viti D. Neri 2000 The use of phage display for the development of tumor targeting agents Adv.Drug Deliv.Rev. 43 165 196
35. N.H. Olson M. Gingery F.A. Eiserling T.S. Baker 2001 The structure of isomeric capsids of bacteriophage T4 Virology 279 385 391
36. S.M. O'Malley A.K. Sattar K.R. Williams E.K. Spicer 1995 Mutagenesis of the COOH-terminal region of bacteriophage T4 regA protein J.Biol.Chem. 270 5107 5114
37. M. Paschke 2006 Phage display systems and their applications Appl.Microbiol.Biotechnol. 70 2 11
38. A. Pirisi 2000 Phage therapy-advantages over antibiotics Lancet 356 1418
39. Z.J. Ren L.W. Black 1998 Phage T4 SOC and HOC display of biologically active, full-length proteins on the viral capsid Gene 215 439 444
40. D. Rennell S.E. Bouvier L.W. Hardy A.R. Poteete 1991 Systematic mutation of bacteriophage T4 lysozyme J.Mol.Biol. 222 67 88
41. T. Sathaliyawala M. Rao D.M. MacLean D.L. Birx C.R. Alving V.B. Rao 2006 Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines Virol. 80 7688 7698
42. 2 moiety affects catalytic activity J.Biol.Chem. 268 880 886
43. H.E. Selick K.N. Kreuzer B.M. Alberts 1988 The bacteriophage T4 vector system A method for introducing site-specific mutations into the virus chromosome J.Biol.Chem. 263 11336 11347
44. A. Sergeeva M.G. Kolonin J.J. Molldrem R. Pasqualini W. Arap 2006 Display technologies: application for the discovery of drug and gene delivery agents Adv.Drug Deliv.Rev. 58 1622 1654
45. S.B. Shivachandra Q. Li K.K. Peachman G.R. Matyas S.H. Leppla C.R. Alving M. Rao V.B. Rao 2006 Multicomponent anthrax toxin display and delivery using bacteriophage T4 Vaccine 25 1225 1235
46. G.P. Smith 1985 Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228 1315 1316
47. R. Stone 2002 Stalin's forgotten cure Science 298 728 731
48. A. Sulakvelidze Z. Alavidze J.G. Morris Jr. 2001 Bacteriophage therapy Antimicrob.Agents Chemother. 45 649 659
49. K. Switala-Jelen K. Dabrowska A. Gorski L. Sliwa 2002 Mutations in bacteriophage T4 genome Ada Virol. 46 57 62
50. F. Toart F. Repoila C. Monod H.M. Kirsch 1996 Bacteriophage T4 host range is expanded by duplications of a small domain of the tail fiber adhesion J.Mol.Biol. 258 726 731
51. B. Weber-Dabrowska M. Mulczyk A. Gorski 2000 Bacteriophage therapy of bacterial infections: an update of our institute experience Arch.Immunol.Ther. Exp. 48 547 551
52. W.G.T. Willats 2002 Phage display: practicalities and prospects Plant Mol.Biol. 50 837 854
53. J. Wu C. Tu X. Yu M. Zhang N. Zhang M. Zhao W. Nie Z. Ren 2006 Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: A powerful immunological approach J.Virol.Meth. 139 50 60
54. M. Yoichi M. Abe K. Miyanaga H. Unno Y. Tanji 2005 Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7 J.Biotechnol. 115 101 107
55. C. Yong-Chang S. Quan-Cheng M. Jing-Yun X. Quing-Mei B. Ying-Zuo 2005 Vaccination against very virulent infectious bursal disease virus using recombinant T4 bacteriophage displaying viral protein VP2 Acta Biochem.Biophys.Sinica 37 657 664